AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Top 13%
#647 out of 5254 analysts
Average Return
+8.7%
Win Rate
43%76 out of 177
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Opus Genetics IncIRD | +488.54% | $0.98 | $5.75 | 2025-06-26 - 2026-04-17 | Buy |
Opus Genetics IncIRD | +400.00% | $0.91 | $4.55 | 2025-03-31 - 2026-03-31 | Buy |
Phathom Pharmaceuticals IncPHAT | +377.90% | $2.76 | $13.19 | 2025-05-01 - 2026-04-17 | Buy |
Surrozen IncSRZN | +294.50% | $8.00 | $31.56 | 2025-05-11 - 2026-04-17 | Buy |
Zenas Biopharma IncZBIO | +271.61% | $8.77 | $32.59 | 2024-12-15 - 2025-12-15 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Fibrobiologics IncFBLG | 10 | Buy | $8.00 | +422.88% | Maintains | 4 days ago |
Kodiak Sciences IncKOD | 10 | Buy | $58.00 | +29.18% | Reiterates | 24 days ago |
Surrozen IncSRZN | 4 | Buy | $36.00 | +14.07% | Reiterates | a month ago |
4d Molecular Therapeutics IncFDMT | 19 | Buy | $36.00 | +243.18% | Reiterates | a month ago |
Aldeyra Therapeutics IncALDX | 14 | Hold | $2.00 | +11.11% | Downgrades | a month ago |
Zenas Biopharma IncZBIO | 6 | Buy | $44.00 | +101.65% | Reiterates | a month ago |
Immunic IncIMUX | 8 | Buy | $5.00 | +400.00% | Maintains | 2 months ago |
Ardelyx IncARDX | 2 | Buy | $18.00 | +179.07% | Maintains | 2 months ago |
Akebia Therapeutics IncAKBA | 4 | Buy | $6.00 | +327.05% | Reiterates | 2 months ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $5.00 | +14.68% | Downgrades | 5 months ago |
Mineralys Therapeutics IncMLYS | 13 | Buy | $56.00 | +83.13% | Maintains | 5 months ago |
Phathom Pharmaceuticals IncPHAT | 11 | Buy | $26.00 | +97.12% | Maintains | 6 months ago |
Tarsus Pharmaceuticals IncTARS | 2 | Buy | $88.00 | +30.87% | Maintains | 6 months ago |
Diamedica Therapeutics IncDMAC | 7 | Buy | $12.00 | +75.18% | Reiterates | 8 months ago |
Lyra Therapeutics IncLYRA | 8 | Hold | $16.00 | +3,100.00% | Reiterates | 8 months ago |
Lenz Therapeutics IncLENZ | 7 | Buy | $56.00 | +450.10% | Maintains | 9 months ago |
Opus Genetics IncIRD | 13 | Buy | $8.00 | +39.13% | Reiterates | 10 months ago |
Unity Biotechnology IncUNBX | 9 | Hold | $2.00 | +900.00% | Downgrades | a year ago |
Optinose IncOPTN | 8 | Hold | $9.00 | -6.25% | Reiterates | a year ago |
Hillevax IncHLVX | 5 | Hold | $2.00 | N/A | Reiterates | a year ago |
Opthea LtdOPTEY | 7 | Hold | $2.00 | N/A | Downgrades | a year ago |
Hyperion Defi IncHYPD | 16 | Hold | $2.00 | N/A | Reiterates | a year ago |
FabrinetFN | 1 | Buy | $28.00 | N/A | Reiterates | 3 years ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.